MedTrace Logo

Alzheimer's Prevention Through Exercise

NCT02000583 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 117

Last updated 2020-07-28

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to learn about the possible benefits of aerobic exercise in controlling or reducing the amount of amyloid present in the brain, reducing changes in brain structure that may lead to Alzheimer's Disease (AD), and increasing cognitive ability in individuals that have amyloid deposits and are at risk to develop AD.

Conditions

Interventions

OTHER

Aerobic Exercise

Aerobic group participants will engage in 150 minutes of aerobic exercise over 4-5 days per week for 52 weeks

OTHER

Standard of Care

Control group participants will be provided educational materials on starting an exercise program, but will receive no formal support for their exercise program.

Sponsors & Collaborators

  • National Institute on Aging (NIA)

    collaborator NIH

  • University of Kansas Medical Center

    lead OTHER

Principal Investigators

  • Jeffrey Burns, MD · University of Kansas Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02000583 on ClinicalTrials.gov